Scinai Immunotherapeutics
Ness Ziona · Founded 2003
About Scinai Immunotherapeutics
Scinai Immunotherapeutics is a biopharmaceutical company that focuses on research and development, manufacturing, and commercialization of innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.
Company Facts
- Founded: 2003
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $89.1M
- Funding stage: IPO
- Last round: Grant (Oct 2025)
- Ticker: nasdaq:SCNI
- Website: https://www.scinai.com
- Phone: +972-8-930-2529
Industries & Categories
Biotechnology, Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/scinai-immunotherapeutics-51927 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.